X
Have any questions?
Our Carla Verissimo, Head of Oncology II speaks about the current challenges of oncology drug development in this exclusive interview of the PREDiCT series.
Exclusive Interview with Carla Verissimo, Head of Oncology II, HUB Organoid Technology.